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Barnett and Prineas1 recently reported new morphological findings in the brain of a 
14-year-old patient with relapsing-remitting multiple sclerosis (MS) who died within 
24 hours of the onset of a new symptomatic and fatal brainstem lesion. Within this 
early lesion, they observed extensive oligodendrocyte cell death which they attributed 
to apoptosis. Strikingly, no T lymphocytes were detected in the region of 
oligodendrocyte death. In an accompanying editorial, Trapp2 suggests that this finding 
indicates that the immune response in MS is not the cause of the oligodendrocyte cell 
death but is secondary to oligodendrocyte death caused by an unknown primary 
disease mechanism. Before accepting this interpretation, two points need to be 
considered. First, the patient reported by Barnett and Prineas received an intravenous 
injection of 100mg hydrocortisone.1 Corticosteroid administration reduces the number 
of T lymphocytes in the central nervous system in rats with experimental autoimmune 
encephalomyelitis (EAE).3 This commences as early as 4 hours after subcutaneous 
corticosteroid administration.3 A dose of 0.25mg dexamethasone/kg (equivalent to 
6.7mg hydrocortisone/kg) inhibits the development of EAE by an effect on 
lymphocyte migration rather than by inducing T-lymphocyte apoptosis.4 Assuming a 
body weight of 50kg for the patient reported by Barnett and Prineas, the dose of 
hydrocortisone administered was 2mg/kg, which might have been sufficient to clear T 
lymphocytes from the central nervous system after these cells had induced 
oligodendrocyte death. Second, even in the absence of T lymphocytes, 
antioligodendrocyte antibody can induce oligodendrocyte death and consequent 
demyelination in the absence of complement and macrophages.5 Such a mechanism 
also needs to be considered in MS. 
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